Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Matt_Gline
|
| gptkbp:country |
gptkb:Switzerland
gptkb:United_States |
| gptkbp:focus |
drug development
acquisition of underdeveloped drugs |
| gptkbp:foundedBy |
gptkb:Vivek_Ramaswamy
|
| gptkbp:foundedIn |
2014
|
| gptkbp:founder |
gptkb:Vivek_Ramaswamy
|
| gptkbp:headquartersLocation |
gptkb:New_York_City
Basel |
| https://www.w3.org/2000/01/rdf-schema#label |
Roivant Sciences Ltd.
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notablePerson |
gptkb:Vivek_Ramaswamy
gptkb:Matt_Gline |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:ROIV
|
| gptkbp:subsidiary |
gptkb:Axovant_Sciences
gptkb:Genevant_Sciences gptkb:Dermavant_Sciences gptkb:Enzyvant_Sciences gptkb:Immunovant gptkb:Myovant_Sciences gptkb:Urovant_Sciences |
| gptkbp:website |
https://www.roivant.com/
|
| gptkbp:bfsParent |
gptkb:Roivant_Sciences
|
| gptkbp:bfsLayer |
5
|